These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8977334)

  • 21. Helicobacter pylori infection increases mucosal permeability of the stomach and intestine.
    Fukuda Y; Bamba H; Okui M; Tamura K; Tanida N; Satomi M; Shimoyama T; Nishigami T
    Digestion; 2001; 63 Suppl 1():93-6. PubMed ID: 11173917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosa.
    Wex T; Ye S; Treiber G; Vieth M; Roessner A; Malfertheiner P
    Helicobacter; 2006 Feb; 11(1):31-8. PubMed ID: 16423087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corticosteroid therapy augments gastroduodenal permeability to sucrose.
    Kiziltaş S; Imeryüz N; Gürcan T; Siva A; Saip S; Dumankar A; Kalayci C; Ulusoy NB
    Am J Gastroenterol; 1998 Dec; 93(12):2420-5. PubMed ID: 9860402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study.
    Uemura N; Sugano K; Hiraishi H; Shimada K; Goto S; Uchiyama S; Okada Y; Origasa H; Ikeda Y;
    J Gastroenterol; 2014 May; 49(5):814-24. PubMed ID: 23754512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study.
    Kono Y; Okada H; Takenaka R; Miura K; Kanzaki H; Hori K; Kita M; Tsuzuki T; Kawano S; Kawahara Y; Yamamoto K
    Gut Liver; 2016 Jan; 10(1):69-75. PubMed ID: 26087789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biphasic effects of H. pylori infection on low-dose aspirin-induced gastropathy depending on the gastric acid secretion level.
    Iijima K; Ara N; Abe Y; Koike T; Iwabuchi T; Shinkai H; Uno K; Endo H; Asano N; Shimosegawa T
    J Gastroenterol; 2012 Dec; 47(12):1290-7. PubMed ID: 22549566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs.
    Smecuol E; Bai JC; Sugai E; Vazquez H; Niveloni S; Pedreira S; Mauriño E; Meddings J
    Gut; 2001 Nov; 49(5):650-5. PubMed ID: 11600467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interrelationships between Helicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal disease. A prospective study in healthy volunteers.
    Thillainayagam AV; Tabaqchali S; Warrington SJ; Farthing MJ
    Dig Dis Sci; 1994 May; 39(5):1085-9. PubMed ID: 8174421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is Helicobacter pylori infection a risk or protective factor for mucosal lesions development in patients chronically treated with acetylsalicylic acid?
    Kordecki H; Kurowski M; Kosik R; Pilecka D
    J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():85-91. PubMed ID: 9440059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Helicobacter pylori and eradication therapy on gastrointestinal permeability. Implications for patients with seronegative spondyloarthritis.
    Di Leo V; D'Inca R; Bettini MB; Podswiadek M; Punzi L; Mastropaolo G; Sturniolo GC
    J Rheumatol; 2005 Feb; 32(2):295-300. PubMed ID: 15693091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of regular and enteric-coated aspirin on gastroduodenal mucosa of man.
    Hoftiezer JW; Silvoso GR; Burks M; Ivey KJ
    Lancet; 1980 Sep; 2(8195 pt 1):609-12. PubMed ID: 6107406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heat shock protein 70 (HSP70) in gastric adaptation to aspirin in Helicobacter pylori infection.
    Konturek JW; Fischer H; Konturek PC; Huber V; Boknik P; Luess H; Neumann J; Brzozowski T; Schmitz W; Hahn EG; Domschke W; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):153-64. PubMed ID: 11321509
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early ultrastructural changes of antral mucosa with aspirin in the absence of Helicobacter pylori.
    McCarthy CJ; Sweeney E; O'Morain C
    J Clin Pathol; 1995 Nov; 48(11):994-7. PubMed ID: 8543644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of 24 hours of aspirin, Bufferin, paracetamol and placebo on normal human gastroduodenal mucosa.
    Hoftiezer JW; O'Laughlin JC; Ivey KJ
    Gut; 1982 Aug; 23(8):692-7. PubMed ID: 7095565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori and nonsteroidal antiinflammatory drugs: partners in crime?
    Jones NL; Sherman P; Wang B; Inman RD
    Bull Rheum Dis; 1997 Dec; 46(8):6-8. PubMed ID: 9409058
    [No Abstract]   [Full Text] [Related]  

  • 36. Gastrointestinal permeability following aspirin intake and prolonged running.
    Ryan AJ; Chang RT; Gisolfi CV
    Med Sci Sports Exerc; 1996 Jun; 28(6):698-705. PubMed ID: 8784758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
    Nakao K; Imoto I; Ikemura N; Shibata T; Takaji S; Taguchi Y; Misaki M; Yamauchi K; Yamazaki N
    Am J Gastroenterol; 1997 Jun; 92(6):1005-11. PubMed ID: 9177520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
    Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyamine profile in human gastric mucosa infected by Helicobacter pylori.
    Linsalata M; Russo F; Notarnicola M; Berloco P; Di Leo A
    Ital J Gastroenterol Hepatol; 1998 Oct; 30(5):484-9. PubMed ID: 9836101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of Helicobacter pylori infection and low-dose aspirin in the upper gastrointestinal tract: implications for clinical practice.
    Leung Ki EL; Chan FK
    Best Pract Res Clin Gastroenterol; 2012 Apr; 26(2):163-72. PubMed ID: 22542154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.